These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 24306668)
1. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. Choi ES; Kim HS; Han I Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668 [TBL] [Abstract][Full Text] [Related]
2. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506 [TBL] [Abstract][Full Text] [Related]
3. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma. Li Y; Liu X; Zhang J; Yao W Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma. Strojnik T; Smigoc T; Lah TT Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340 [TBL] [Abstract][Full Text] [Related]
8. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer. Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer]. Bień E; Balcerska A Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy. Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922 [TBL] [Abstract][Full Text] [Related]
11. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer. Seong MK J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054 [TBL] [Abstract][Full Text] [Related]
13. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer]. Wang X; Li K Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918 [TBL] [Abstract][Full Text] [Related]
14. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma. Nakamura T; Grimer R; Gaston C; Francis M; Charman J; Graunt P; Uchida A; Sudo A; Jeys L Eur J Cancer; 2013 Jan; 49(2):377-85. PubMed ID: 23058786 [TBL] [Abstract][Full Text] [Related]
15. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205 [TBL] [Abstract][Full Text] [Related]
16. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942 [TBL] [Abstract][Full Text] [Related]
17. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy. Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582 [TBL] [Abstract][Full Text] [Related]
19. USE OF NEUTROPHILS TO LYMPHOCYTES RATIO AS AN INFLAMMATION MARKER IN PATIENTS WITH CHRONIC TONSILLITIS. Sahin C; Varim C; Uyanık M Georgian Med News; 2016 Oct; (259):62-65. PubMed ID: 27845289 [TBL] [Abstract][Full Text] [Related]
20. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers. Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]